EPBU- 2016 contract status

Quote
anonymous said:
Only if you're a good 'ol boy or someone whose as crooked as they are. I was on a contract and watched them roll managers (more exclusively) off a contract and only one or two reps. The rep they rolled over was quite young, spaced out on scheduled ADHD meds, and half living in an alternate reality.
Click to expand...
This is referring specifically to being rolled from one contract to another.
 






























Anonymous said:
Right now the EPBU is contracted through July 1, 2016. Does anyone have any actual insight into whether we will get an extension? My manager says all indications are we will continue with the contract. I'm concerned because budgeting is already completed at Merck and we still have no news with only 6ish months left.
Click to expand...




We were told by text from our Manager that the contract has been signed I would like a formal email to come out now?
 
























Anonymous said:
Right now the EPBU is contracted through July 1, 2016. Does anyone have any actual insight into whether we will get an extension? My manager says all indications are we will continue with the contract. I'm concerned because budgeting is already completed at Merck and we still have no news with only 6ish months left.
Click to expand...

Do the math... 2 1/2 months away. Look for another job. You never get the straight scoop from Publicis so don't even try.
 




































Do you think the managers knew the ending was coming? Mine didn't give any hint at all. Who do you think will promote Dulera and Asmanex? The cardiovascular primary care reps since Zetia and going generic soon or the Respiratory reps? They have huge territories and Grasstek is not doing well.
 






The question I have is why did our managers tell us they extended contract 8 weeks ago. Were they anticipating Merck would agree and they lied to us? Should tell us a lot about character and integrity our co has.
 












I'm not defending Merck or Touchpoint, but just to put things in perspective, the contract was indeed extended as all of us were told. At the time, no one really expected it to end. No lies here folks. But also you should all be mature enough to realize that this contract (just like any other contract by any other CSO with any other manufacturer) always provides a clause where the manufacturer can always opt out at anytime (even if agreements have already been made to extended it). Of course, there are penalties to be paid if they prematurely terminate the contract, as the case will be with this one. Obviously Merck decided it was in its best interest to opt out of the contract (despite it being just being extended) and pay the fines.
 






anonymous said:
Do you think the managers knew the ending was coming? Mine didn't give any hint at all. Who do you think will promote Dulera and Asmanex? The cardiovascular primary care reps since Zetia and going generic soon or the Respiratory reps? They have huge territories and Grasstek is not doing well.
Click to expand...

They have a team now called "Team 3" and they will carry Dulera, Asmanex and Belsomra.
 






Top Bottom
Back
Quote